Faculty

Christina Ha

MD, FACG, AGAF
Director, Inflammatory Bowel Diseases Section
Mayo Clinic Arizona

Dr. Christina Ha completed her internal medicine residency and fellowship at the Washington University in St. Louis School of Medicine and then received additional training as the Present-Levison Inflammatory Bowel Diseases Fellow at the Mount Sinai School of Medicine. She is Director of the Inflammatory Bowel Disease Section and Associate Professor of Medicine at Mayo Clinic Arizona. Her clinical research interests focus on the impact of aging on the natural history of the inflammatory bowel diseases, especially the pathogenesis and natural history of late-onset IBD. She is also very involved in IBD related trainee educational initiatives and has served on multiple committees within the Crohn’s and Colitis Foundation, American College of Gastroenterology, and American Gastroenterological Association.

2024 Sessions

Managing Complications and Extraintestinal Manifestations of UC

This session will provide an overview of the different extraintestinal manifestations of inflammatory bowel disease, symptoms and features warranting a referral to specialist colleagues, and initial recommendations for treatment of extraintestinal manifestations.

Faculty

Moderator

Thursday, April 04 2:15–3:00 PM
Faculty

Christina Ha

MD, FACG, AGAF
Director, Inflammatory Bowel Diseases Section
Mayo Clinic Arizona

Dr. Christina Ha completed her internal medicine residency and fellowship at the Washington University in St. Louis School of Medicine and then received additional training as the Present-Levison Inflammatory Bowel Diseases Fellow at the Mount Sinai School of Medicine. She is Director of the Inflammatory Bowel Disease Section and Associate Professor of Medicine at Mayo Clinic Arizona. Her clinical research interests focus on the impact of aging on the natural history of the inflammatory bowel diseases, especially the pathogenesis and natural history of late-onset IBD. She is also very involved in IBD related trainee educational initiatives and has served on multiple committees within the Crohn’s and Colitis Foundation, American College of Gastroenterology, and American Gastroenterological Association.

Moderator

Millie Long

MD, MPH, FACG
Professor of Medicine
University of North Carolina at Chapel Hill

Millie D. Long MD, MPH earned her doctor of medicine degree at the University of Virginia. She completed a residency and chief residency in internal medicine at the University of Alabama at Birmingham. She then completed a gastroenterology fellowship at University of North Carolina. She also completed a fellowship in preventive medicine and a masters of public health in epidemiology at the Gillings School of Public Health. She is board certified in internal medicine, preventive medicine, and gastroenterology. She is currently Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of North Carolina, as well as Chief of the Division.

Dr. Long’s clinical practice is at the UNC Multidisciplinary Inflammatory Bowel Diseases (IBD) center. Her research interests include prevention of complications of IBD, women’s health and clinical epidemiology. Dr. Long has contributed over 200 peer-reviewed publications, book chapters, and review articles to the literature. She co-authored the 2025 ACG ulcerative colitis guidelines. She serves Co-Editor in Chief of the American Journal of Gastroenterology.

Dr. Long is a fellow of the American College of Gastroenterology where she is a member of the Board of Trustees. She is also a fellow of the American Gastroenterological Association and a member of the Crohn’s and Colitis Foundation. Recipient of the 2024 Sherman Prize for Excellence in Crohn’s and Colitis. She is a member of the International Organization for the Study of IBD.

Back to top